Cancer Immunotherapy Treatment

Understanding Immunotherapy

Immunotherapy is an advanced cancer treatment approach that helps the body’s immune system recognize and fight cancer cells. Unlike conventional treatments that directly target cancer cells, immunotherapy works by strengthening or modifying the body’s natural immune response.

There are different types of immunotherapy, and each works in a specific way. The treating oncologists will carefully evaluate your medical records, cancer type, disease stage, and overall health to determine which immunotherapy approach may be suitable for your condition.

1. Checkpoint Inhibitors (PD-1/PD-L1)

Checkpoint inhibitors are medications that help restore the immune system’s ability to recognize and attack cancer cells. They work by blocking specific proteins, such as PD-1 and PD-L1, that cancer cells use to suppress immune responses.

Common Indications:

• Melanoma
• Non-small cell lung cancer
• Kidney cancer
• Cervical cancer

May Be Suitable For: Patients whose tumors have relevant biomarker results, such as PD-L1 expression, or individuals who may benefit from immunotherapy after standard treatments.

Clinical Use: Checkpoint inhibitors can be administered alone (monotherapy) or in combination with other cancer treatments, depending on the diagnosis and treatment plan.

2. CAR-T Cell Therapy

Chimeric Antigen Receptor T-cell (CAR-T) therapy is an advanced form of cell-based immunotherapy. It involves collecting a patient’s T-cells and modifying them in a laboratory so they can recognize and attack specific cancer cells.

After modification, these cells are infused back into the patient to help fight cancer.

Common Indications:

• Acute lymphoblastic leukemia
• B-cell lymphoma
• Selected other blood cancers

May Be Suitable For: Patients with certain treatment-resistant (refractory) or recurrent blood cancers who meet the clinical eligibility criteria.

Clinical Use: CAR-T is a personalized cellular treatment that may be considered after other therapies have not provided sufficient results. Its use requires specialist assessment and careful monitoring.

3. CIK Immunotherapy

Cytokine-Induced Killer (CIK) cell therapy is a type of cellular immunotherapy that uses immune cells to help target and destroy cancer cells.

During this process, immune cells are collected from the patient and expanded in a laboratory under controlled conditions. These cells are then infused back into the patient to support the immune response against cancer.

Common Indications:

• Selected solid tumors
• Certain hematological cancers

May Be Suitable For: Depending on the clinical situation, CIK therapy may be considered for patients who require additional immune-based treatment or postoperative supportive therapy.

Clinical Use: CIK therapy may be used as an adjunctive treatment approach to support cancer management. Its potential role in reducing recurrence depends on the cancer type and available clinical evidence.

Next Steps for Your Case

Choosing the right immunotherapy requires a detailed medical evaluation. Not every immunotherapy approach is suitable for every cancer type or patient.

At Global 360 Care, our team helps coordinate specialist consultations with the treating oncologists. We can assist with submitting your medical records, pathology reports, biomarker results, and diagnostic scans for professional review.

The specialists will evaluate your condition and determine whether checkpoint inhibitors, CAR-T cell therapy, CIK immunotherapy, or another treatment approach may be appropriate.

They will also explain the expected benefits, potential side effects, treatment requirements, and follow-up care based on your individual medical needs.

Contact Global 360 Care to arrange a specialist review and explore available cancer immunotherapy options.